T. Kaufman

Prednisone, etoposide, procarbazine, and cyclophosphamide (PEP‐C) oral combination chemotherapy regimen for recurring/refractory lymphoma: Low‐dose metronomic, multidrug therapy

J. Leonard, R. Elstrom, R. Furman, 2008, Cancer.

Combinatorial Anti-Tumor Activity in Animal Models of a Novel CD123 x CD3 Bispecific Dart® Molecule (MGD024) with Cytarabine, Venetoclax or Azacitidine Supports Combination Therapy in Acute Myeloid Leukemia

P. Moore, Ling Huang, E. Bonvini, 2021, Blood.

DICE (dexamethasone, ifosfamide, cisplatin, etoposide) infusional chemotherapy for refractory or relapsed non-Hodgkin's lymphoma (NHL).

M. Coleman, J. Leonard, T. Kaufman, 2001, European journal of haematology. Supplementum.

Augmented therapy of extensive Hodgkin's disease: radiation to known disease or prolongation of induction chemotherapy did not improve survival--results of a Cancer and Leukemia Group B study.

K. Propert, N. Nissen, B. Peterson, 1998, International journal of radiation oncology, biology, physics.